iSpecimen Inc. Operating Loss Carryforwards
iSpecimen Inc. (ISPC) had Operating Loss Carryforwards of $50.90 million as of 2025-03-31, per its 10-Q filed 2025-05-19.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2025-05-19
- 2025-03-31: Operating Loss Carryforwards $50.90M.
- 2024-12-31: Operating Loss Carryforwards $36.10M; Operating Loss Carryforwards as first filed $49.40M.
| Period end | Operating Loss Carryforwards | Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-03-31 | $50.90M 10-Q · filed 2025-05-19 | |
| 2024-12-31 | $36.10M 10-Q · filed 2025-05-19 | $49.40M 10-K · filed 2025-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |